Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aviron nasal spray flu vaccine PLA filing in children and adults planned for mid-1998.

Executive Summary

AVIRON NASAL SPRAY FLU VACCINE PLA FILING PLANNED FOR MID-1998 based on data from a Phase III trial in children and an upcoming study in healthy adults. Mountain View, Calif.-based Aviron and the National Institute of Allergy and Infectious Diseases, which co-funded the pediatric trial, announced initial results of the study with the live, attenuated cold-adapted influenza vaccine on July 14.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030528

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel